Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 177,695 | 257,996 | 253,637 | 217,696 | 319,589 |
| Marketable Securities | 641,991 | 589,023 | 508,359 | 463,881 | 436,404 |
| Receivables | 148,231 | 139,438 | 119,686 | 113,714 | 104,695 |
| Inventories | 34,670 | 29,097 | 26,124 | 22,948 | 21,949 |
| TOTAL | $1,062,113 | $1,076,422 | $960,553 | $870,942 | $938,318 |
| Non-Current Assets | |||||
| PPE Net | 7,511 | 3,708 | 3,547 | 3,498 | 4,215 |
| Intangibles | 108,893 | 111,615 | 114,338 | 117,060 | 119,782 |
| Other Non-Current Assets | 385,678 | 139,026 | 147,117 | 140,864 | 125,441 |
| TOTAL | $502,082 | $254,349 | $265,002 | $261,422 | $249,438 |
| Total Assets | $1,564,195 | $1,330,771 | $1,225,555 | $1,132,364 | $1,187,756 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,903 | 21,747 | 20,097 | 18,095 | 16,192 |
| Accrued Expenses | 266,211 | 334,837 | 309,927 | 284,435 | 378,678 |
| TOTAL | $277,114 | $356,584 | $330,024 | $302,530 | $394,870 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 59,691 | 56,915 | 73,149 | 64,597 | 60,093 |
| TOTAL | $59,691 | $56,915 | $73,149 | $64,597 | $60,093 |
| Total Liabilities | $336,805 | $413,499 | $403,173 | $367,127 | $454,963 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 170,495 | 169,182 | 168,712 | 167,362 | 166,789 |
| Common Shares | 16 | 16 | 16 | 16 | 16 |
| Retained earnings | -1,813,386 | -2,086,954 | -2,158,733 | -2,185,399 | -2,204,386 |
| Other shareholders' equity | 1,445 | 989 | 406 | 437 | 292 |
| TOTAL | $1,227,390 | $917,272 | $822,382 | $765,237 | $732,793 |
| Total Liabilities And Equity | $1,564,195 | $1,330,771 | $1,225,555 | $1,132,364 | $1,187,756 |